GlassScriptPhysician profile
Abha Ojha Kathuria
NPI 1295984300
$10,714.55
in general payments reported to CMS, 2019-2025
16 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.82 · 2021: $214 · 2022: $345 · 2023: $152 · 2024: $9,395 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,726 · Travel and Lodging: $2,834 · Food and Beverage: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,725.51 |
| Travel and Lodging | $2,834.21 |
| Food and Beverage | $1,580.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,301.98 | 2024-2025 | |
| Convatec INC. | $2,254.40 | 2024-2025 | |
| Kerecis Limited | $225.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $190.84 | 2022 | |
| Boston Scientific Corporation | $132.21 | 2022 | |
| Silk Road Medical, INC. | $122.04 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Mozarc Medical US LLC | $108.33 | 2024 | Argyle |
| Innovation Technologies INC | $107.02 | 2021 | |
| Smith+Nephew, INC. | $106.45 | 2021-2023 | Versajet |
| Organogenesis INC. | $50.44 | 2025 | Nushield, Cygnus Dual |
| Baxter Healthcare | $27.08 | 2024 | Renal - Pd |
| Hydrofera LLC | $22.31 | 2022 | |
| Acera Surgical, INC. | $20.61 | 2025 | Restrata Wound Matrix |
| Teleflex LLC | $16.35 | 2021 | |
| Misonix INC | $14.82 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $14.34 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abha Ojha Kathuria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.